Pharmaceuticals

Global Non-Therapeutic Biomolecules Market 2026–2030: Forecast Insights for Business Planning

February 17, 2026February 17, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the non-therapeutic biomolecules market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Non-Therapeutic Biomolecules Market expected to reach by 2030?

The non-therapeutic biomolecules market has experienced substantial expansion in recent years. It is forecast to increase from $33.92 billion in 2025 to $37.59 billion in 2026, at a compound annual growth rate (CAGR) of 10.8%. The historical growth of this market can be linked to an escalating demand for research biomolecules, wider implementation in in vitro diagnostics, an increase in pharmaceutical research endeavors, innovations in recombinant protein technology, and strengthened alliances between biotechnology firms.

The non-therapeutic biomolecules market is anticipated to experience substantial expansion in the forthcoming years, with its valuation expected to reach $56.43 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This projected growth over the forecast period is fueled by several factors, including the increasing application of synthetic biomolecules, rising investment in precision medicine, enhanced usage in agricultural biotechnology, a heightened emphasis on sustainable and scalable biomolecule production, and breakthroughs in automated biomolecule synthesis platforms. Prominent trends identified for this period encompass advanced protein engineering, high-throughput screening technologies, sustainable biomolecule production, cell-free biomolecule synthesis, and customizable biomolecule platforms.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

What Drivers Are Driving Adoption Within The Non-Therapeutic Biomolecules Market?

The escalating volume of research and laboratory testing is anticipated to drive expansion in the non-therapeutic biomolecules market in the future. Laboratory testing involves medical procedures where samples like blood or urine are analyzed to identify and track diseases and develop treatment strategies. Meanwhile, research signifies the generation of novel knowledge or the inventive application of existing knowledge to form new concepts, theories, and insights. Within laboratory testing, non-therapeutic biomolecules are employed to gauge the existence or level of biomarker molecules signaling illness, thereby improving the test’s sensitivity and specificity. For example, the National Health Service (NHS), a UK-based hospital and health care provider, reported in July 2024 that diagnostic activities surpassed pre-pandemic figures in 2023, with a 21% rise in tests conducted in May 2024 compared to 2023. Consequently, the expanding volume of research and laboratory testing is fueling the development of the non-therapeutic biomolecules market.

How Is The Non-Therapeutic Biomolecules Market Organized Into Various Segments?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

3) By Application: Diagnostic Equipment, Therapeutic Equipment, Monitoring Or Imaging Equipment, Laboratory Or Research Equipment, Rehabilitation Or Mobility Support

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

Which Trends Are Guiding The Evolution Of The Non-Therapeutic Biomolecules Market?

Within the non-therapeutic biomolecules market, leading companies are prioritizing the development of advanced cell separation technology to elevate throughput and refine processes, thereby securing a competitive advantage. This novel research-only kit is designed to offer scientists a critical solution to complex biological and laboratory workflow issues. For instance, in May 2023, AcouSort AB, a biotechnology company based in Sweden, unveiled its AcouTrap 3 system. The system integrates the distinct properties of acoustofluidics, which combines sound waves with microfluidics, to deliver an optimized solution for the isolation of cells and extracellular vesicles in a singular workflow. Employing gentle acoustic trapping technology, the AcouTrap 3 system allows scientists to manage a larger number of samples with enhanced cell viability and minimal loss when contrasted with conventional column- or bead-based methodologies, consequently boosting productivity and streamlining laboratory operations.

Who Are The Primary Competitors In The Global Non-Therapeutic Biomolecules Market?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Eppendorf AG, Bio-Techne Corporation, Vectalys, Avid Bioservices Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Non-Therapeutic Biomolecules Market?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2025. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Non-Therapeutic Biomolecules Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp

Browse Through More Reports Similar to the Global Non-Therapeutic Biomolecules Market 2026, By The Business Research Company

Non Therapeutic Biomolecules Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Peptide Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Bioengineered Protein Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/bioengineered-protein-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795